胰岛素增敏剂
尽管在治疗高甘油三酯血症方面没有针对性的新药问世,但值得注意的是,一些胰岛素增敏药物可通过影响过氧化物酶体增生物激活受体而产生降低甘油三酯水平的效果。尽管噻唑烷二酮类药物是糖尿病的治疗用药,但这些药物有降低甘油三酯的显著作用。[52]Rizzo M, Christ ER, Rini GB, et al. The differential effects of thiazolidinediones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert Opin Pharmacother. 2008 Sep;9(13):2295-303.http://www.ncbi.nlm.nih.gov/pubmed/18710354?tool=bestpractice.com[53]Spanheimer R, Betteridge DJ, Tan MH, et al. Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14). Am J Cardiol. 2009 Jul 15;104(2):234-9.http://www.ncbi.nlm.nih.gov/pubmed/19576353?tool=bestpractice.com 进行中的遗传研究可帮助识别具有产生胰岛素耐受高风险的个体,有利于较早地干预生活方式或采取其它措施。